BACKGROUND: Understanding the experiences of men leaving active surveillance programs is critical to making such programs viable for men with localized prostate cancer. OBJECTIVE: To generate hypotheses about the factors that influence patients' decisions to leave an active surveillance program. METHODS: Using data from the Johns Hopkins active surveillance cohort, bivariate analyses and multinomial regression models examined characteristics of men who self-elected to leave, those who stayed in the program, and those who left because of disease reclassification. We interviewed patients who self-elected to leave. RESULTS: Of 1,159 men in active surveillance, 9 % self-elected to leave. In interviews with a sample of 14 men who self-elected to leave, uncertainty involved in active surveillance participation, existence of personal criteria-distinct from providers' clinical criteria-and fear of cancer were important factors in decisions to leave. CONCLUSION: Men leaving active surveillance were motivated by a number of factors, including patient-defined criteria, which might differ from clinical recommendations. To ensure active surveillance participation, it may be important to address cancer-related anxiety and personal criteria underlying patient decisions.
BACKGROUND: Understanding the experiences of men leaving active surveillance programs is critical to making such programs viable for men with localized prostate cancer. OBJECTIVE: To generate hypotheses about the factors that influence patients' decisions to leave an active surveillance program. METHODS: Using data from the Johns Hopkins active surveillance cohort, bivariate analyses and multinomial regression models examined characteristics of men who self-elected to leave, those who stayed in the program, and those who left because of disease reclassification. We interviewed patients who self-elected to leave. RESULTS: Of 1,159 men in active surveillance, 9 % self-elected to leave. In interviews with a sample of 14 men who self-elected to leave, uncertainty involved in active surveillance participation, existence of personal criteria-distinct from providers' clinical criteria-and fear of cancer were important factors in decisions to leave. CONCLUSION:Men leaving active surveillance were motivated by a number of factors, including patient-defined criteria, which might differ from clinical recommendations. To ensure active surveillance participation, it may be important to address cancer-related anxiety and personal criteria underlying patient decisions.
Authors: Jeffrey J Tosoian; Bruce J Trock; Patricia Landis; Zhaoyong Feng; Jonathan I Epstein; Alan W Partin; Patrick C Walsh; H Ballentine Carter Journal: J Clin Oncol Date: 2011-04-04 Impact factor: 44.544
Authors: Patricia A Ganz; John M Barry; Wylie Burke; Nananda F Col; Phaedra S Corso; Everett Dodson; M Elizabeth Hammond; Barry A Kogan; Charles F Lynch; Lee Newcomer; Eric J Seifter; Janet A Tooze; Kasisomayajula Viswanath; Hunter Wessells Journal: Ann Intern Med Date: 2012-02-20 Impact factor: 25.391
Authors: Steven B Zeliadt; Peggy A Hannon; Ranak B Trivedi; Laura M Bonner; Thuy T Vu; Carol Simons; Crystal A Kimmie; Elaine Y Hu; Chris Zipperer; Daniel W Lin Journal: BMC Med Inform Decis Mak Date: 2013-02-06 Impact factor: 2.796
Authors: Maximilian F Lang; Mark D Tyson; JoAnn Rudd Alvarez; Tatsuki Koyama; Karen E Hoffman; Matthew J Resnick; Matthew R Cooperberg; Xiao-Cheng Wu; Vivien Chen; Lisa E Paddock; Ann S Hamilton; Mia Hashibe; Michael Goodman; Sheldon Greenfield; Sherrie H Kaplan; Antoinette Stroup; David F Penson; Daniel A Barocas Journal: Urology Date: 2017-02-09 Impact factor: 2.649
Authors: Stacy Loeb; Caitlin Curnyn; Angela Fagerlin; R Scott Braithwaite; Mark D Schwartz; Herbert Lepor; H Ballentine Carter; Shannon Ciprut; Erica Sedlander Journal: Patient Educ Couns Date: 2017-09-01
Authors: Claire Kim; Frances C Wright; Nicole J Look Hong; Gary Groot; Lucy Helyer; Pamela Meiers; May Lynn Quan; Robin Urquhart; Rebecca Warburton; Anna R Gagliardi Journal: PLoS One Date: 2018-02-05 Impact factor: 3.240